Preferred Label : 13-valent pneumococcal vaccine;
MeSH hyponym : PCV13 vaccine; PCV-13 vaccine; prevenar 13; prevnar 13;
Is substance : O;
Origin ID : C538862;
UMLS CUI : C3152625;
ATC code(s)
- Automatic exact mappings (from CISMeF team)
- MeSH indexing information
- MeSH term(s) associated for indexing
- Record concept(s)
- Semantic type(s)
- UMLS correspondences (same concept)
- Vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4,
5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F capsular polysaccharide antigens (medicinal
product) [SNOMED CT concept]
https://publications.msss.gouv.qc.ca/msss/document-002648/
2024
false
false
false
Canada
quebec
Invasive Streptococcus pneumoniae disease (disorder)
immunization schedule
infant
10-valent pneumococcal vaccine
13-valent pneumococcal vaccine
Asplenia
hemoglobinopathies
hematopoietic stem cell transplantation
scientific and technical information
pneumococcal infections
vaccination
child
immunization programs
adult
pneumococcal vaccines
vaccination
pneumococcal vaccines
---
https://www.health.belgium.be/fr/avis-9562-vaccination-antipneumococcique-adultes
2020
false
false
false
Belgium
French
English
Dutch
German
vaccination
belgium
aged
pneumococcal infections
immunization schedule
10-valent pneumococcal vaccine
13-valent pneumococcal vaccine
Immunogenicity, Vaccine
immunization, secondary
risk factors
Invasive Streptococcus pneumoniae disease (disorder)
guideline
adult
pneumococcal vaccines
vaccination
---
https://www.has-sante.fr/jcms/p_3195261/fr/prevenar-13
2020
false
false
false
France
French
evaluation of the transparency committee
insurance, health, reimbursement
pneumococcus, purified polysaccharides antigen conjugated
13-valent pneumococcal vaccine
child
adolescent
pneumonia, pneumococcal
otitis media
pneumococcal infections
Invasive Streptococcus pneumoniae disease (disorder)
vaccination
risk factors
injections, intramuscular
pneumococcal vaccines
---
https://www.has-sante.fr/portail/jcms/c_2973623/fr/prevenar-13
2019
false
false
false
France
French
evaluation of the transparency committee
insurance, health, reimbursement
adult
immunocompromised host
disease susceptibility
pneumonia, pneumococcal
vaccination
13-valent pneumococcal vaccine
polysaccharides, bacterial
pneumococcal vaccines
---
https://www.has-sante.fr/portail/jcms/c_2973611/fr/prevenar-13
2019
false
true
false
France
French
evaluation of the transparency committee
pneumococcus, purified polysaccharides antigen conjugated
pneumococcal infections
injections, intramuscular
pneumococcal vaccines
vaccines, conjugate
polysaccharides, bacterial
streptococcus pneumoniae
infant
child
adolescent
otitis media
pneumonia, pneumococcal
acute disease
adult
Invasive Streptococcus pneumoniae disease (disorder)
treatment outcome
drug therapy, combination
insurance, health, reimbursement
Otitis media acute
antibiotic therapy
13-valent pneumococcal vaccine
---
https://www.inspq.qc.ca/publications/2574
2019
false
false
false
Canada
comparative effectiveness research
10-valent pneumococcal vaccine
13-valent pneumococcal vaccine
Cost-Benefit analysis
pneumococcal infections
quebec
drug costs
economic evaluation
pneumococcal vaccines
---
https://minerva-ebp.be/fr/analyses-en-ligne/304
2015
false
true
false
Belgium
French
french abstract
scientific and technical information
13-valent pneumococcal vaccine
vaccine potency
pneumococcal vaccines
well elder
vaccines, conjugate
age more than 65 years
aged
pneumococcal vaccines
---
http://www.has-sante.fr/portail/jcms/c_1720512/fr/prevenar-13
2014
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
pneumococcus, purified polysaccharides antigen conjugated
pneumococcal infections
injections, intramuscular
pneumococcal vaccines
vaccines, conjugate
polysaccharides, bacterial
streptococcus pneumoniae
infant
child
adolescent
otitis media
pneumonia, pneumococcal
acute disease
adult
Invasive Streptococcus pneumoniae disease (disorder)
treatment outcome
drug therapy, combination
insurance, health, reimbursement
Otitis media acute
antibiotic therapy
13-valent pneumococcal vaccine
---
http://www.has-sante.fr/portail/jcms/c_957703/prevenar-13-vaccin-anti-pneumococcique
http://www.has-sante.fr/portail/jcms/c_939182/prevenar-13
http://www.has-sante.fr/portail/jcms/c_1638937/fr/prevenar-13
http://www.has-sante.fr/portail/jcms/c_1638936/fr/prevenar-10072013-avis-ct12284
2013
false
France
French
antibiotic therapy
13-valent pneumococcal vaccine
pneumococcal vaccines
pneumococcal infections
vaccination
vaccines, conjugate
pneumococcus, purified polysaccharides antigen conjugated
insurance, health, reimbursement
child
infant
pneumonia, pneumococcal
otitis media
polysaccharides, bacterial
streptococcus pneumoniae
injections, intramuscular
immunization schedule
treatment outcome
pneumococcal vaccines
evaluation of the transparency committee
guidelines for drug use
adult
---
https://www.ema.europa.eu/medicines/human/EPAR/Prevenar-13
2012
false
United Kingdom
French
English
syndication feed
13-valent pneumococcal vaccine
pneumococcal vaccines
pneumococcal vaccines
vaccination
drug approval
drug labeling
treatment outcome
immunization schedule
injections, intramuscular
polysaccharides, bacterial
infant
child
streptococcus pneumoniae
pneumococcal infections
vaccines, conjugate
pneumococcus, purified polysaccharides antigen conjugated
summary of product characteristics
package leaflet
drug evaluation
---
